Yi Bao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yi Bao has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Linhui Wang
Department of Urology, Changhai Hospital, Naval Medical University, Shanghai, China
2 shared publications Tangliang Zhao
Department of Urology, Changzheng Hospital, Second Military Medical University, Shanghai, 200003, China
2 shared publicationsXinxin Gan
Department of Urology, Changzheng Hospital, Second Military Medical University, Shanghai, 200003, China
2 shared publications- Ahmed Saleh Al‐Ansari
School of Veterinary Medicine University College Dublin Dublin Ireland
1 shared publication Anbang Wang
Department of Urology, Changzheng Hospital, Second Military Medical University, Shanghai, 200003, China
1 shared publication- Anbang Wang
Department of Urology, The Second Affiliated Hospital of Naval Medical University, Shanghai, China
1 shared publication
Latest Publications
- 1 January 2020
- Published by Elsevier in Cancer Letters
- Vol. 469, 68-77
CircRNA cRAPGEF5 inhibits the growth and metastasis of renal cell carcinoma via the miR-27a-3p/TXNIP pathway
- 1 January 2020
- Published by Elsevier in Cancer Letters
- Vol. 469, 68-77
CircRNA cRAPGEF5 inhibits the growth and metastasis of renal cell carcinoma via the miR-27a-3p/TXNIP pathway
- 1 August 2019
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 516 (3) , 880-887
ANGPTL3 inhibits renal cell carcinoma metastasis by inhibiting VASP phosphorylation
- 1 August 2019
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 516 (3) , 880-887
ANGPTL3 inhibits renal cell carcinoma metastasis by inhibiting VASP phosphorylation
- Open Access
- 27 February 2013
- Published by Wolters Kluwer Health in Transplantation
- Vol. 95 (4) , 580-588
The Clinical and Molecular Significance of C4d Staining Patterns in Renal Allografts
We investigated the clinical and molecular significance of minimal peritubular capillary (PTC) and isolated glomerular C4d+ staining using microarrays. Two hundred fifty-five clinically indicated transplant biopsies were included in the analyses. C4d staining was performed on paraffin sections using a polyclonal rabbit anti-C4d antibody. Gene expression profiles in a subset of patients were studied using Affymetrix HuGene 1.0ST arrays. Immunohistochemistry for C4d of 255 biopsies showed 51% C4d negative, 4% minimal PTC C4d+, 15% focal or diffuse PTC C4d+, and 31% isolated glomerular C4d+ biopsies. Patients with minimal and focal/diffuse PTC C4d+ staining had higher frequency of donor-specific anti-HLA antibodies (DSA) (67% and 82%) and antibody mediated rejection (AMR) (66% and 89%) when compared with C4d-negative biopsies (25% and 19%, respectively) (P<0.001). The glomerulitis, interstitial inflammation, and peritubular capillaritis scores were also significantly higher in minimal (0.88, 1.25, and 1.5) and focal/diffuse PTC C4d+ biopsies (0.65, 1.41, and 1.5), compared with C4d-negative biopsies (0.25, 079, and 0.34), respectively. There were no differences in the DSA frequency, AMR rate, or Banff scores between isolated glomerular C4d+ and C4d-negative patients. Although both minimal and focal/diffuse C4d+ biopsies showed increased expression of genes related to the immune response, interferon-gamma and rejection-induced, cytotoxic T cell and constitutive macrophage-associated pathogenesis-based transcripts, there was no activation of immune-response–related genes in isolated glomerular C4d+ biopsies. Minimal PTC C4d+ staining but not isolated glomerular C4d+ staining is associated with AMR, circulating DSAs and immune-response–related gene activation.
- 27 February 2013
- Published by Wolters Kluwer Health in Transplantation
- Vol. 95 (4) , 580-588
Open AccessThe Clinical and Molecular Significance of C4d Staining Patterns in Renal Allografts
We investigated the clinical and molecular significance of minimal peritubular capillary (PTC) and isolated glomerular C4d+ staining using microarrays. Two hundred fifty-five clinically indicated transplant biopsies were included in the analyses. C4d staining was performed on paraffin sections using a polyclonal rabbit anti-C4d antibody. Gene expression profiles in a subset of patients were studied using Affymetrix HuGene 1.0ST arrays. Immunohistochemistry for C4d of 255 biopsies showed 51% C4d negative, 4% minimal PTC C4d+, 15% focal or diffuse PTC C4d+, and 31% isolated glomerular C4d+ biopsies. Patients with minimal and focal/diffuse PTC C4d+ staining had higher frequency of donor-specific anti-HLA antibodies (DSA) (67% and 82%) and antibody mediated rejection (AMR) (66% and 89%) when compared with C4d-negative biopsies (25% and 19%, respectively) (P<0.001). The glomerulitis, interstitial inflammation, and peritubular capillaritis scores were also significantly higher in minimal (0.88, 1.25, and 1.5) and focal/diffuse PTC C4d+ biopsies (0.65, 1.41, and 1.5), compared with C4d-negative biopsies (0.25, 079, and 0.34), respectively. There were no differences in the DSA frequency, AMR rate, or Banff scores between isolated glomerular C4d+ and C4d-negative patients. Although both minimal and focal/diffuse C4d+ biopsies showed increased expression of genes related to the immune response, interferon-gamma and rejection-induced, cytotoxic T cell and constitutive macrophage-associated pathogenesis-based transcripts, there was no activation of immune-response–related genes in isolated glomerular C4d+ biopsies. Minimal PTC C4d+ staining but not isolated glomerular C4d+ staining is associated with AMR, circulating DSAs and immune-response–related gene activation.